Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli

Article Abstract:

Previous studies have reported that Escherichia coli accumulate guanosine 3',5'-bispyrophosphate (ppGpp) and in consequence, develop penicillin tolerance, as a stringent response under conditions of amino acid deprivation. During the stringent response, synthesis of peptidoglycan and penicillin-induced lysis are inhibited in the amino acid-deprived cells. In a recent study of E. coli, peptidoglycan synthesis and penicillin tolerance were shown to result from the inhibition of phospholipid synthesis and not from the production of ppGpp as earlier suggested. This indicates that peptidoglycan metabolism is dependent on phospholipid synthesis during growth of E. coli.

Author: Rodionov, Dmitrii G., Ishiguro, Edward E.
Publisher: Society for General Microbiology
Publication Name: Microbiology
Subject: Biological sciences
ISSN: 1350-0872
Year: 1996
Phospholipids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Antibiotics, peptidoglycan synthesis and genomics: The chlamydial anomaly revisited

Article Abstract:

Peptidoglycan, a cell wall polymer, forms a sacculus around most eubacteria. Chlamydia trachomatis and C. pneumoniae are obligate intracellular eubacteria having a unique development cycle, with one form the infectious elementary body (EB), adapted to extracellular survival. It is believed that even if EBs contain peptidoglycan, it is in insufficient quantities to form a sacculus imparting structural stability. The growth of peptidoglycan-containing bacteria is inhibited by penicillin and other Beta-lactam antibiotics, through inhibition of penicillin-binding proteins (PBPs). Data shows that Chlamydia spp. can synthesize peptidoglycan.

Author: Chopra, Ian, Storey, Christopher, Falla, Timothy J., Pearce, John H.
Publisher: Society for General Microbiology
Publication Name: Microbiology
Subject: Biological sciences
ISSN: 1350-0872
Year: 1998
Research, Antibiotics, Chlamydia trachomatis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


In situ proton-NMR analyses of Escherichia coli HB101 fermentations in (sup)1H(sub)2O and in D(sub)2O

Article Abstract:

This paper describes in-process monitoring of Escherichia coli fermentation in normal and heavy water solvents using Fourier-trnsform proton-NMR spectrometry. Results show that the technique is rapid and versatile for simultaneous, direct and automatic analyses of compounds in the fermentation media.

Author: Brecker, Lothar, Weber, Hansjorg, Griengl, Herfried, Ribbons, Douglas W.
Publisher: Society for General Microbiology
Publication Name: Microbiology
Subject: Biological sciences
ISSN: 1350-0872
Year: 1999
Austria, Analysis, Usage, Fermentation, Nuclear magnetic resonance spectroscopy, Heavy water

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Escherichia coli, Peptidoglycans
Similar abstracts:
  • Abstracts: Homofermentative production of D- or L-lactate in metabolically engineered Escherichia coli RR1
  • Abstracts: RNA polymerase, PurR and MetR interactions at the glyA promoter of Escherichia coli. Rickettsia prowazekii sigma factor sigma-73 can be overexpressed in Escherichia coli and promotes RNA polymerase binding and transcription
  • Abstracts: Conversion of dTDP-4-keto-6-deoxyglucose to free dTDP-4-keto-rhamnose by the rmlC gene products of Escherichia coli and Mycobacterium tuberculosis
  • Abstracts: Molecular mechanisms in cell-mediated cytotoxicity. A Notch affair
  • Abstracts: Rapid invasion by colicinogenic Escherichia coli with novel immunity functions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.